Inhibition of p38 enhances ERK inhibitor efficacy in pancreatic ductal adenocarcinoma

被引：0
|
作者：
Ryan, Meagan B.
Bryant, Kirsten L.
Hayes, Tikvah K.
Kher, Swapnil
Wood, Kris C.
Samatar, Ahmed A.
Cox, Adrienne D.
Der, Channing J.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4660
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4660
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Inhibition of epithelial-to-mesenchymal transition augments antitumor efficacy of nanotherapeutics in pancreatic ductal adenocarcinoma
    Jin, Kai-Zhou
    Wu, Ying
    Zheng, Xiao-Xiao
    Li, Tian-Jiao
    Liao, Zhen-Yu
    Fei, Qing-Lin
    Zhang, Hui-Ru
    Shi, Sai-Meng
    Sha, Xin
    Yu, Xian-Jun
    Chen, Wei
    Ye, Long-Yun
    Wu, Wei-Ding
    FEBS JOURNAL, 2023, 290 (18) : 4577 - 4590
  • [42] Inhibition of PP2A enhances the osteogenic differentiation of human aortic valvular interstitial cells via ERK and p38 MAPK pathways
    Xie, Fei
    Li, Fei
    Li, Rui
    Liu, Zongtao
    Shi, Jiawei
    Zhang, Chao
    Dong, Nianguo
    LIFE SCIENCES, 2020, 257
  • [43] Selective inhibition of the T cell p38 alternative activation pathway and pancreatic cancer
    Alam, Muhammad
    Gaida, Matthias
    Bergmann, Frank
    Lasitschka, Felix
    Giese, Thomas
    Giese, Nathalia
    Hackert, Thilo
    Hinz, Ulf
    Hossain, S.
    Kozlov, Serguei
    Ashwell, Jonathan
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [44] p38 inhibitor inhibits the apoptosis of cowanin-treated human colorectal adenocarcinoma cells
    Chowchaikong, Nittiya
    Nilwarangkoon, Sirinun
    Laphookhieo, Surat
    Tanunyutthawongse, Chantra
    Watanapokasin, Ramida
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (06) : 2031 - 2040
  • [45] Inhibition of a lower potency target drives the anticancer activity of a clinical p38 inhibitor
    Bhattacharjee, Debanjan
    Bakar, Jaweria
    Chitnis, Surbhi P.
    Sausville, Erin L.
    Ashtekar, Kumar Dilip
    Mendelson, Brianna E.
    Long, Kaitlin
    Smith, Joan C.
    Heppner, David E.
    Sheltzer, Jason M.
    CELL CHEMICAL BIOLOGY, 2023, 30 (10) : 1211 - +
  • [46] Inhibition of collagen-induced arthritis with an inhibitor of p38 MAP kinase.
    Brahn, E
    Protter, AA
    Schoettler, N
    Banquerigo, ML
    Almirez, R
    Mavunkel, B
    Scott, B
    Liang, X
    Dugar, S
    Liu, DY
    Chakravarty, S
    Stebbins, E
    Perumattam, J
    Schreiner, GF
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S566 - S566
  • [47] Selective Inhibition of Pancreatic Ductal Adenocarcinoma Cell Growth by the Mitotic MPS1 Kinase Inhibitor NMS-P715
    Slee, Roger B.
    Grimes, Brenda R.
    Bansal, Ruchi
    Gore, Jesse
    Blackburn, Corinne
    Brown, Lyndsey
    Gasaway, Rachel
    Jeong, Jaesik
    Victorino, Jose
    March, Keith L.
    Colombo, Riccardo
    Herbert, Brittney-Shea
    Korc, Murray
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (02) : 307 - 315
  • [48] A novel hedgehog signaling inhibitor for targeting pancreatic ductal adenocarcinoma
    Khire, Atul
    Zhong, Yi
    Rajanala, Kalpana
    Iacobuzio-Donahue, Christine
    Resh, Marilyn D.
    CANCER RESEARCH, 2019, 79 (13)
  • [49] p38 differentially regulates ERK, p21, and mitogenic signalling in two pancreatic carcinoma cell lines
    Monica Aasrum
    G. Hege Thoresen
    Thoralf Christoffersen
    Ingvild J. Brusevold
    Journal of Cell Communication and Signaling, 2018, 12 : 699 - 707
  • [50] p38 differentially regulates ERK, p21, and mitogenic signalling in two pancreatic carcinoma cell lines
    Aasrum, Monica
    Thoresen, G. Hege
    Christoffersen, Thoralf
    Brusevold, Ingvild J.
    JOURNAL OF CELL COMMUNICATION AND SIGNALING, 2018, 12 (04) : 699 - 707
12345